Episode 20. Management of Myeloma in LMICs
Blood Cancer Talks
VRD: The New Standard of Care?
There is no generic lennelitomite in Mexico. That means there's this same issue in the US with the patent wars and all of these interesting strategies by industry to these patents. We don't have formal patient advocacy groups. So it's like the Wild West and there's a lot of pushing for the one way but nobody pushing the other way.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
